IRLAB Therapeutics AB (publ) financials at a glance

+ Portfolio

The revenue of IRLAB Therapeutics AB (publ) is reported as 0.00568 billion Kronor in the fiscal year 2023. The earnings were -3.43 Kronor per share in 2023, which was 56.62 lower than 2022. And about -0.16557 billion Kronor are reported as free cash flow in the financials of IRLAB Therapeutics AB (publ) 2023. No dividends were paid to the shareholders of the IRLAB Therapeutics AB (publ) stock OM:IRLAB A in the financial year 2023.

kr5.68M

Revenue

kr-3.43

Earnings Per Share

0.00%

Gross Margin %

kr-,195.00M

Free Cash Flow

Revenue

5.68

Earnings Per Share

-3.43

Gross Margin %

0.00

Free Cash Flow

-,195.00

Financials

Year	Year	TTM	2023	2022	2021	2019	2018	2017	2016
Rev.	Revenue	N/A	kr5.68M	kr61.14M	kr207.78M	kr0.03M	kr0.20M	kr0.11M	kr0.14M
GM %	Gross Margin %	0.00%	0.00%	-,105.94%	60.66%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	-,185.01%	25.30%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	kr-3.39	kr-3.43	kr-2.19	kr1.76	kr-2.37	kr-1.94	kr-1.67	kr-1.75
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	51.87M	51.87M	51.75M	43.11M	40.5M	35M	25.35M
OCF	Operating Cash Flow	N/A	kr-,164.86M	kr-,247.00M	kr0.00M	kr-91.20M	kr0.00M	kr-55.83M	kr0.00M
FCF	Free Cash Flow	N/A	kr-,195.00M	kr-,247.00M	kr0.00M	kr-91.34M	kr0.00M	kr-56.06M	kr0.00M
FCFS	Free Cash Flow Per Share	kr-3.26	kr-3.18	kr-2.82	kr2.47	kr-2.25	kr-1.88	kr-1.72	kr-1.69

IRLAB Therapeutics AB (publ) financials at a glance

Financials

Discover